No admission of liability but lots of money being thrown in the direction of claimants.
Bloomberg has the latest update regarding the huge settlements GlaxoSmithKline are making with regard to the Paxil lawsuits in America. They are reporting that GSK has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children.
Furthermore they add:
The birth-defect settlements bring to more than $2 billion the amount Glaxo has agreed to pay to resolve a variety of Paxil-related suits, including claims it caused suicides or attempted suicides and addiction problems.
GlaxoSmithKline's Sarah Alspach chipped in with the obligatory...
“GSK believes it acted properly and responsibly in conducting its clinical trial program, in marketing the medicine, in monitoring its safety once it was approved for use and in updating pregnancy information in the medicine’s label as new information became available.”
GlaxoSmithKline are the subject of a UK Group Action. The case goes to trial later this year.
The Seroxat Group Action claims are being pursued under the Consumer Protection Act [CPA] 1987.
The CPA provides for a non-fault based liability if the product is found to be defective and to have caused injury as a result. The Claimants allege difficulties in withdrawing from the drug.
The action is due for trial in the High Court in London later this year.
As yet, GlaxoSmithKline, have made no approach to settle this particular case despite settling with US litigants in similar withdrawal cases.
In all honesty, I would just love it if GlaxoSmithKline stood in the High Court and presented evidence that suggested there *wasn't* a problem regarding Paxil withdrawal. The items of disclosure obtained by the claimant's lawyers would then become public and I would love nothing more than to upload them for the whole world to see on here.
The full Bloomberg article can be read HERE
Last year Glaxo were ordered to pay $2.5million over claims that its Paxil antidepressant caused birth defects. Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxil’s risk. The panel awarded $2.5 million in compensatory damages to the family of Lyam Kilker. The 3-year-old was born with heart defects his mother blamed on the drug.
Glaxo appealed the decision but have since settled.
The court transcripts from the GSK V Kilker trial can be viewed here:
All documents from the Tracey Law Firm
9/15/09 AM: Opening Statements
9/15/09 PM: David Healy, M.D. -- Direct Examination
9/16/09 AM: David Healy, M.D. -- Direct (continued)
9/17/09 AM: David Healy, M.D. -- Cross Examination
9/17/09 PM: David Healy, M.D. -- Recross; Redirect
9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination
9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)
9/22/09 AM: Suzanne Parisian, M.D. -- Cross Examination
9/22/09 PM: Suzanne Parisian, M.D. -- Redirect; Recross
9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination
9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect
9/23/09 AM: Ra-id Abdulla, M.D. -- Direct Examination
9/23/09 PM: Ra-id Abdulla, M.D. -- Cross Examination; Redirect
9/29/09 AM: Anthony Scialli, M.D. -- Direct Examination
9/29/09 PM: Anthony Scialli, M.D. -- Cross Examination
9/30/09 AM: Anthony Scialli, M.D. -- Redirect; Recross
9/30/09 AM: Stephen Hobbiger, BSC -- Direct Examination
9/30/09 PM: Stephen Hobbiger, BSC -- Cross Examination; Redirect
10/1/09 AM: H. Scott Baldwin, M.D. -- Direct Examination
10/1/09 PM: H. Scott Baldwin, M.D. -- Cross; Redirect; Recross
10/2/09 AM: Judith Jones, M.D., PhD -- Direct Examination
10/2/09 AM: Judith Jones, M.D., PhD -- Cross Examination; Redirect
10/6/09 AM: Gary Shaw, PhD -- Direct Examination
10/6/09 PM: Gary Shaw, PhD -- Cross Examination; Redirect
10/8/09 AM: Closing Arguments -- Plaintiff & Defendant
10/8/09 PM: Closing Arguments -- Plaintiff Rebuttle & Jury Charge
Ra-id Abdulla, M.D., Pediatric Cardiologist, Professor of Pediatrics, Rush University in Chicago
David Healy, M.D., FRCPsych, Neuropyschopharmacologist, Professor of Psychiatry, Cardiff University, University Hospital Wales North Wales Department of Psychological Medicine
Valerie Parisi, RN, Lifecare Planner
Suzanne Parisian, M.D., former FDA employee
Shira Kramer, Ph.D., Epidemiologist
H. Scott Baldwin, M.D., Pediatric Cardiologist, Children's Hospital at Vanderbilt
Stephen Hobbiger, BSC, Vice President of Neuroscience, Global Clinical Safety & Pharmaco Vigilance
Judit Jones, M.D., Ph.D., FDA expert, Clinical Pharmacologist, Pharmacoepidemiologist
Anthony Sciali, M.D., OB/GYN, Reproductive Toxicologist, George Washington University
Gary Shaw, Ph.D., Epidemiologist
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING